mycophenolate

mycophenolate

 [mi″ko-fen´o-lāt]
an immunosuppressant used as mycophenolate mofetil to prevent rejection of allogeneic cardiac, hepatic, and renal transplants; administered orally or intravenously.

mycophenolate

/my·co·pheno·late/ (-fen´o-lāt) an immunosuppressant used as m. mofetil to prevent rejection of allogeneic cardiac, hepatic, and renal transplants.

mycophenolate

(mī-kō-fē′nō-lāt)
An immunosuppressive drug used to prevent organ rejection after transplantation.
References in periodicals archive ?
Tenders are invited for Mycophenolate Mofityl Tab 360 Mg Myfortic 360 Pac Basis
Mycophenolate mofetil (MMF) is an immunosuppressive drug used in solid organ transplant patients and had been reported to be associated with pulmonary fibrosis and organizing pneumonia with no other forms of histopathologic abnormalities documented in the English literature.
After our successful experience with voriconazole, we decided to use the same approach for the implementation of an LC-MS/MS quantification method for the antiepileptic lamotrigine and the immunosuppressant mycophenolate in plasma.
Northbrook, IL, announced this week that ASTAGRAF XL for the prophylaxis of organ rejection in patients receiving a kidney transplant used with mycophenolate mofetil (MMF) and corticosteroids, with or without basiliximab induction, is now available in US pharmacies nationwide.
Ophthalmologists and eye specialists from the US and Europe focus on recent innovative treatment options, but begin with an outline of treatment principles and the most conventional treatments, including corticosteroids and other immunosuppresant agents, then discuss the newer available agents for intraocular inflammation, such as drugs adopted from rheumatology, mycophenolate mofetil, anti-tumor necrosis factor-alpha agents, anti-interleuken therapy, interferon-alpha therapy, rituximab, intravitreal injection therapy, corticosteroid intravitreal implants, and calcineurin inhibitor voclosporin, mammalian target of rapamycin inhibitor sirolumus, and the IL-1 trap rilonacept.
For patients with more severe disease or in any patients when steroids could not be reduced to acceptable levels, immunosuppressive agents such as azathioprine, mycophenolate mofetil, and methotrexate were recommended.
Oral mycophenolate mofetil 500 mg twice a day and oral prednisone 100 mg daily were started.
In mid-March, the patient received mycophenolate mofetil 750 mg twice daily, together with 5 [micro]g/kg/d of recombinant human granulocyte colony-stimulating factor (G-CSF) and 1 mg/kg/day of methyl-prednisolone.
Mycophenolate mofetil (CellCept) also has a category D rating.
All patients received a temporary course of an anti-T cell antibody called basiliximab and the standard transplant drugs mycophenolate mofetil and corticosteroids.
Both Myfortic, known generically as mycophenolic acid, and CellCept, mycophenolate mofetil, are used to suppress the immune system to prevent patients' bodies from rejecting a transplanted organ.
Background: Although mycophenolate mofetil (MMF) has proven efficacy in preventing solid organ allograft rejection in adults, well-established dosing practices have yet to be established in children.